A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer Institute at NYU Langone Medical Center, one of the authors of the study published on-line ahead of print in the Journal of Clinical Oncology.
Full article >>
Tuesday, March 10, 2009
MicroRNA-based Diagnostic Identifies Squamous Lung Cancer with 96% Sensitivity
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment